Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-Oncology Annual Meeting

Stock Information for Tocagen Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tocagen Inc.

Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders
Tocagen Reports First Quarter 2020 Financial Results
Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results
Tocagen and Forte Biosciences Announce Merger
Tocagen Reports Third Quarter 2019 Financial Results and Business Updates
Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting
Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12
Tocagen Announces Restructuring to Focus on Clinical Development

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.